INGREZZA
NDC product · U.S. Food and Drug Administration (openFDA) · United States
-
Product NDC
70370-2048 -
Package NDC
70370-2048-6 -
Application number
NDA209241 -
SPL ID
bbfcd3d3-5b8b-411d-9cb6-3521a4e36e6b -
SPL set ID
4c970164-cafb-421f-9eb5-c226ef0a3417 -
UNII
5SML1T733B -
RxCUI
1918224 -
RxCUI
1918230 -
RxCUI
1986329 -
RxCUI
1986331 -
RxCUI
2054268 -
RxCUI
2054269 -
RxCUI
2541511 -
RxCUI
2541513 -
RxCUI
2665627 -
RxCUI
2665628 -
RxCUI
2680779 -
RxCUI
2680780 -
RxCUI
2680781 -
RxCUI
2680782 -
RxCUI
2680783 -
RxCUI
2680784
What the source publishes
- Labeler
- Neurocrine Biosciences, Inc.
- Active ingredients
- Valbenazine
- Form
- KIT
- Routes
- ORAL
- Administrative status
- present-in-source-snapshot
- Marketing status
- NDA
- Product type
- HUMAN PRESCRIPTION DRUG
- Prescription
- Prescription or restricted
Names this record is found by
Complete source data
{
"name": "INGREZZA",
"splId": "bbfcd3d3-5b8b-411d-9cb6-3521a4e36e6b",
"labels": [
{
"setId": "4c970164-cafb-421f-9eb5-c226ef0a3417",
"labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=4c970164-cafb-421f-9eb5-c226ef0a3417",
"labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=4c970164-cafb-421f-9eb5-c226ef0a3417"
}
],
"routes": [
"ORAL"
],
"labeler": "Neurocrine Biosciences, Inc.",
"finished": true,
"packaging": [
{
"sample": false,
"description": "1 BLISTER PACK in 1 CARTON (70370-2048-6) / 1 KIT in 1 BLISTER PACK",
"package_ndc": "70370-2048-6",
"identifierStatus": "well-formed",
"marketing_start_date": "20181214"
}
],
"productId": "70370-2048_bbfcd3d3-5b8b-411d-9cb6-3521a4e36e6b",
"useDomain": "unknown",
"dosageForm": "KIT",
"productNdc": "70370-2048",
"deaSchedule": null,
"genericName": "Valbenazine",
"productType": "HUMAN PRESCRIPTION DRUG",
"listingStatus": "present-in-source-snapshot",
"targetSpecies": [],
"approvalStatus": "not-established-by-ndc-listing",
"labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
"marketingEndDate": null,
"activeIngredients": [],
"applicationNumber": "NDA209241",
"marketingCategory": "NDA",
"stateRestrictions": {
"status": "not-collected",
"observations": []
},
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "us.fda.ndc"
},
"marketingStartDate": "20181214",
"targetSpeciesStatus": "not-reported",
"prescriptionCategory": "prescription-or-restricted",
"harmonizedIdentifiers": {
"upc": [
"0370370408011",
"0370370404013",
"0370370204019",
"0370370108010",
"0370370406017",
"0370370106016"
],
"unii": [
"5SML1T733B"
],
"rxcui": [
"1918224",
"1918230",
"1986329",
"1986331",
"2054268",
"2054269",
"2541511",
"2541513",
"2665627",
"2665628",
"2680779",
"2680780",
"2680781",
"2680782",
"2680783",
"2680784"
],
"spl_set_id": [
"4c970164-cafb-421f-9eb5-c226ef0a3417"
],
"manufacturer_name": [
"Neurocrine Biosciences, Inc."
],
"is_original_packager": [
true
]
},
"listingExpirationDate": "20271231"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=us" \
--data-urlencode "sourceId=us.fda.ndc" \
--data-urlencode "id=us:fda:ndc:70370-2048_bbfcd3d3-5b8b-411d-9cb6-3521a4e36e6b"